Context

Context of FDA integrity issues : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, second session, on Visx Incorporated document disclosure, July 31, 1996
Processing Feedback ...